Discontinued — last reported Q4 '16
Humana Short-Term Investments increased by 8.3% to $17.01B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from $17.89B to $17.01B. Over 4 years (FY 2021 to FY 2025), Short-Term Investments shows an upward trend with a 4.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.
Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...
Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.
short_term_investments| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.19B | $13.88B | $14.93B | $15.25B | $16.63B | $16.70B | $17.42B | $19.03B | $18.21B | $17.89B | $17.67B | $16.74B | $15.70B | $17.01B |
| QoQ Change | — | +5.2% | +7.6% | +2.1% | +9.0% | +0.4% | +4.4% | +9.2% | -4.3% | -1.8% | -1.2% | -5.3% | -6.2% | +8.3% |
| YoY Change | — | +5.2% | — | — | +19.8% | +11.8% | +14.2% | — | +9.6% | +7.1% | +1.4% | -12.1% | -13.8% | -4.9% |